Our company has been very busy, and speeding up
Anson to Commence Brine Sampling at Cane Creek 32-1 Highlights: • Purchase of Cane Creek 32-1 oil and gas well and lease completed • Government process transferring ownership completed • Sampling of brine for lithium to commence in early March 2018 • Program expected to be completed by end March 2018 Anson Resources Limited (Anson) has completed the acquisition of the Cane Creek 32-1 oil well and associated oil and gas lease at its Paradox Lithium Project, located in the “Lithium Four Corners” area in Utah. After the successful extraction of the super saturated brines from the Gold Bar Unit #2 Well in late January 2018, this well provides an excellent opportunity to collect additional samples and geological data to provide an understanding of the structure of the basin and what controls, if any, the structures have on the concentrations of lithium. Assay results from the first stage of the exploration program at Gold Bar Unit 2 are still pending.
- Forums
- ASX - By Stock
- ASN
- Ann: Anson to Commence Brine Sampling at Cane Creek 32-1
Ann: Anson to Commence Brine Sampling at Cane Creek 32-1, page-2
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
-0.001(1.47%) |
Mkt cap ! $92.77M |
Open | High | Low | Value | Volume |
6.8¢ | 6.9¢ | 6.6¢ | $140.8K | 2.096M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 255554 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 115643 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 155555 | 0.067 |
4 | 939410 | 0.066 |
7 | 767516 | 0.065 |
2 | 220000 | 0.064 |
2 | 340000 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 115643 | 3 |
0.070 | 19745 | 1 |
0.071 | 3000 | 1 |
0.072 | 57234 | 2 |
0.073 | 37777 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ASN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online